Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress

BACKGROUND: As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare services normalize, there is an urgent need to reassess...

Descripción completa

Detalles Bibliográficos
Autores principales: Blach, Sarah, Brown, Kimberly A., Brown, Robert S., Gholam, Pierre M., Terrault, Norah A., Estes, Chris, Razavi, Homie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674561/
https://www.ncbi.nlm.nih.gov/pubmed/36473359
http://dx.doi.org/10.1016/j.jiph.2022.11.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674561/
https://www.ncbi.nlm.nih.gov/pubmed/36473359
http://dx.doi.org/10.1016/j.jiph.2022.11.021

Ejemplares similares